Form 424B5 Atara Biotherapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
ATARA Biotherapeutics supplements prospectus for stock offering
May 12, 2026 4:44 PM EDT(Updated - May 12, 2026 4:46 PM EDT)
ATARA Biotherapeutics Inc. (NASDAQ: ATRA) filed a prospectus supplement that allows the company to continue offering common stock under its existing sales agreement despite changes in regulatory requirements.
The biotechnology company filed the second supplement to its sales agreement... More
